The stock of Acadia Healthcare Company Inc (NASDAQ:ACHC) hit a new 52-week low and has $32.72 target or 7.00% below today’s $35.18 share price. The 8 months bearish chart indicates high risk for the $3.00B company. The 1-year low was reported on Nov, 1 by Barchart.com. If the $32.72 price target is reached, the company will be worth $210.00 million less.
The 52-week low event is an important milestone for every stock because it shows very negative momentum and is time when sellers come in. During such technical setups, fundamental investors usually stay away and are careful buying the stock. About 498,408 shares traded hands. Acadia Healthcare Company Inc (NASDAQ:ACHC) has declined 35.14% since March 30, 2016 and is downtrending. It has underperformed by 38.15% the S&P500.
Acadia Healthcare Company Inc (NASDAQ:ACHC) Ratings Coverage
Out of 10 analysts covering Acadia Healthcare (NASDAQ:ACHC), 9 rate it a “Buy”, 0 “Sell”, while 1 “Hold”. This means 90% are positive. Acadia Healthcare has been the topic of 16 analyst reports since August 6, 2015 according to StockzIntelligence Inc. JP Morgan initiated the stock with “Neutral” rating in Wednesday, September 16 report. As per Thursday, August 6, the company rating was maintained by Mizuho. Robert W. Baird maintained the shares of ACHC in a report on Thursday, September 15 with “Outperform” rating. On Friday, April 29 the stock rating was maintained by Mizuho with “Buy”. The firm earned “Buy” rating on Wednesday, October 19 by UBS. The firm has “Outperform” rating by RBC Capital Markets given on Wednesday, October 19. The firm has “Overweight” rating by KeyBanc Capital Markets given on Monday, February 1. RBC Capital Markets maintained Acadia Healthcare Company Inc (NASDAQ:ACHC) on Monday, August 1 with “Outperform” rating. Zacks upgraded Acadia Healthcare Company Inc (NASDAQ:ACHC) on Thursday, August 6 to “Hold” rating. The stock of Acadia Healthcare Company Inc (NASDAQ:ACHC) has “Outperform” rating given on Tuesday, September 1 by Leerink Swann.
According to Zacks Investment Research, “Acadia Healthcare Company, Inc. provides inpatient behavioral health care services. It provides psychiatric and chemical dependency services, including inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and therapeutic school-based programs. Acadia Healthcare Company, Inc. is headquartered in Franklin, Tennessee.”
Insitutional Activity: The institutional sentiment decreased to 1.25 in Q2 2016. Its down 0.09, from 1.34 in 2016Q1. The ratio worsened, as 32 funds sold all Acadia Healthcare Company Inc shares owned while 70 reduced positions. 34 funds bought stakes while 94 increased positions. They now own 85.76 million shares or 4.92% more from 81.74 million shares in 2016Q1.
Loomis Sayles & L P last reported 0.06% of its portfolio in the stock. Northern Tru Corporation holds 0.01% or 501,625 shares in its portfolio. Blackrock Ltd Liability Company holds 0% of its portfolio in Acadia Healthcare Company Inc (NASDAQ:ACHC) for 34,241 shares. Amalgamated Savings Bank last reported 9,780 shares in the company. Marsico Cap Mgmt Limited Co last reported 78,555 shares in the company. Dekabank Deutsche Girozentrale accumulated 56,000 shares or 0.03% of the stock. First Quadrant Lp Ca last reported 0.02% of its portfolio in the stock. Massmutual Tru Fsb Adv has invested 0% of its portfolio in Acadia Healthcare Company Inc (NASDAQ:ACHC). State Of Wisconsin Board holds 0.06% of its portfolio in Acadia Healthcare Company Inc (NASDAQ:ACHC) for 286,252 shares. Shaker Invs Ltd Liability Oh last reported 13,730 shares in the company. Alpine Woods Cap Llc owns 7,650 shares or 0.03% of their US portfolio. Raymond James And Associate holds 46,025 shares or 0.01% of its portfolio. The Ontario – Canada-based Td Asset Mgmt has invested 0.02% in Acadia Healthcare Company Inc (NASDAQ:ACHC). Focused Wealth Inc has 400 shares for 0.01% of their US portfolio. Rock Springs Mngmt Limited Partnership accumulated 837,000 shares or 3.43% of the stock.
Insider Transactions: Since August 5, 2016, the stock had 0 insider purchases, and 10 insider sales for $139.31 million net activity. Fincher Ronald Morgan also sold $462,536 worth of Acadia Healthcare Company Inc (NASDAQ:ACHC) on Monday, August 8. Another trade for 828,534 shares valued at $40.10M was made by WAUD CAPITAL PARTNERS II – L.L.C. on Wednesday, September 14. On Wednesday, September 14 WAUD REEVE B sold $66.04 million worth of the stock or 1.36M shares. On Friday, August 5 GOLDBERG RANDALL P sold $190,044 worth of the stock or 3,626 shares. 29,954 shares were sold by WAUD CAPITAL PARTNERS III – L.L.C., worth $1.55 million on Monday, September 12. Duckworth David M. sold $905,681 worth of Acadia Healthcare Company Inc (NASDAQ:ACHC) on Monday, August 15.
More news for Acadia Healthcare Company Inc (NASDAQ:ACHC) were recently published by: Fool.com, which released: “Why Acadia Healthcare Company Inc. Reported Lower Today” on October 19, 2016. Schaeffersresearch.com‘s article titled: “Analyst Update: Acadia Healthcare Company Inc, VASCO Data Security …” and published on October 19, 2016 is yet another important article.
ACHC Company Profile
Acadia Healthcare Company, Inc., incorporated on October 24, 2005, is a well-known provider of behavioral healthcare services. The Firm operates in two divisions: U.S. Facilities and U.K. Facilities. The Firm develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities and facilities providing outpatient behavioral healthcare services to serve the behavioral health and recovery needs of communities throughout the United States, the United Kingdom and Puerto Rico. The Firm operates approximately 260 behavioral healthcare facilities with over 9,900 beds in over 40 states, the United Kingdom and Puerto Rico.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.